Literature DB >> 18567981

Prevention of premature mortality among patients with schizophrenia: the need for primary prevention efforts in cardiovascular disease.

Charles H Hennekens1.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18567981     DOI： 10.1017/s1092852900003114

Source DB:  PubMed          Journal:  CNS Spectr        ISSN： 1092-8529            Impact factor:   3.790


× No keyword cloud information.
  2 in total

1.  Olanzapine and fluoxetine combination therapy for treatment-resistant depression: review of efficacy, safety, and study design issues.

Authors:  William V Bobo; Richard C Shelton
Journal:  Neuropsychiatr Dis Treat       Date:  2009-07-02       Impact factor: 2.570

2.  Prevalence of metabolic syndrome among patients with schizophrenia in Palestine.

Authors:  Waleed M Sweileh; Sa'ed H Zyoud; Salah A Dalal; Sami Ibwini; Ansam F Sawalha; Iyad Ali
Journal:  BMC Psychiatry       Date:  2012-12-27       Impact factor: 3.630
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.